121 related articles for article (PubMed ID: 27553405)
1. Efficacy of gene-therapy based on adenovirus encoding granulocyte-macrophage colony-stimulating factor in drug-sensitive and drug-resistant experimental pulmonary tuberculosis.
Francisco-Cruz A; Mata-Espinosa D; Ramos-Espinosa O; Marquina-Castillo B; Estrada-Parra S; Xing Z; Hernández-Pando R
Tuberculosis (Edinb); 2016 Sep; 100():5-14. PubMed ID: 27553405
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapeutic effects of recombinant adenovirus encoding granulocyte-macrophage colony-stimulating factor in experimental pulmonary tuberculosis.
Francisco-Cruz A; Mata-Espinosa D; Estrada-Parra S; Xing Z; Hernández-Pando R
Clin Exp Immunol; 2013 Mar; 171(3):283-97. PubMed ID: 23379435
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy using IL-2 and GM-CSF is a potential treatment for multidrug-resistant Mycobacterium tuberculosis.
Zhang Y; Liu J; Wang Y; Xian Q; Shao L; Yang Z; Wang X
Sci China Life Sci; 2012 Sep; 55(9):800-6. PubMed ID: 23015129
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer.
Cao X; Huang X; Ju DW; Zhang W; Hamada H; Wang J
Cancer Gene Ther; 2000 Feb; 7(2):177-86. PubMed ID: 10770625
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapeutic effects of recombinant adenovirus encoding interleukin 12 in experimental pulmonary tuberculosis.
Mata-Espinosa DA; Francisco-Cruz A; Marquina-Castillo B; Barrios-Payan J; Ramos-Espinosa O; Bini EI; Xing Z; Hernández-Pando R
Scand J Immunol; 2019 Mar; 89(3):e12743. PubMed ID: 30548932
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated granulocyte-macrophage colony-stimulating factor improves lung pathology of pulmonary alveolar proteinosis in granulocyte-macrophage colony-stimulating factor-deficient mice.
Zsengellér ZK; Reed JA; Bachurski CJ; LeVine AM; Forry-Schaudies S; Hirsch R; Whitsett JA
Hum Gene Ther; 1998 Sep; 9(14):2101-9. PubMed ID: 9759936
[TBL] [Abstract][Full Text] [Related]
7. Keratinocyte growth factor administration attenuates murine pulmonary mycobacterium tuberculosis infection through granulocyte-macrophage colony-stimulating factor (GM-CSF)-dependent macrophage activation and phagolysosome fusion.
Pasula R; Azad AK; Gardner JC; Schlesinger LS; McCormack FX
J Biol Chem; 2015 Mar; 290(11):7151-9. PubMed ID: 25605711
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of recombinant adenovirus encoding interferon-gamma in a murine model of progressive pulmonary tuberculosis.
Mata-Espinosa DA; Mendoza-Rodríguez V; Aguilar-León D; Rosales R; López-Casillas F; Hernández-Pando R
Mol Ther; 2008 Jun; 16(6):1065-72. PubMed ID: 18431363
[TBL] [Abstract][Full Text] [Related]
9. A significant therapeutic effect of immunoglobulins administered alone, or in combination with conventional chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains.
Olivares N; Rodriguez Y; Zatarain-Barron ZL; Marquina B; Mata-Espinosa D; Barrios-Payán J; Parada C; Moguel B; Espitia-Pinzón C; Estrada I; Hernandez-Pando R
Pathog Dis; 2017 Dec; 75(9):. PubMed ID: 29186408
[TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
11. Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection.
Gonzalez-Juarrero M; Hattle JM; Izzo A; Junqueira-Kipnis AP; Shim TS; Trapnell BC; Cooper AM; Orme IM
J Leukoc Biol; 2005 Jun; 77(6):914-22. PubMed ID: 15767289
[TBL] [Abstract][Full Text] [Related]
12. Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor.
Lee CT; Wu S; Ciernik IF; Chen H; Nadaf-Rahrov S; Gabrilovich D; Carbone DP
Hum Gene Ther; 1997 Jan; 8(2):187-93. PubMed ID: 9017422
[TBL] [Abstract][Full Text] [Related]
13. Immune Regulatory Effect of Osteopontin Gene Therapy in a Murine Model of Multidrug Resistant Pulmonary Tuberculosis.
Hernández-Bazán S; Mata-Espinosa D; Lozano-Ordaz V; Ramos-Espinosa O; Barrios-Payán J; López-Casillas F; Hernández Pando R
Hum Gene Ther; 2022 Oct; 33(19-20):1037-1051. PubMed ID: 35615876
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated combined P16 gene and GM-CSF gene therapy for the treatment of established tumor and induction of antitumor immunity.
Wang L; Qi X; Sun Y; Liang L; Ju D
Cancer Gene Ther; 2002 Oct; 9(10):819-24. PubMed ID: 12224022
[TBL] [Abstract][Full Text] [Related]
15. Thyroid cancer immuno-therapy with retroviral and adenoviral vectors expressing granulocyte macrophage colony stimulating factor and interleukin-12 in a rat model.
Tanaka K; Towata S; Nakao K; Mizuguchi H; Hayakawa T; Niwa M; Ishii N; Nagayama Y
Clin Endocrinol (Oxf); 2003 Dec; 59(6):734-42. PubMed ID: 14974915
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional rates of granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, interleukin-3, and macrophage colony-stimulating factor genes in activated cord versus adult mononuclear cells: alteration in cytokine expression may be secondary to posttranscriptional instability.
Lee SM; Knoppel E; van de Ven C; Cairo MS
Pediatr Res; 1993 Nov; 34(5):560-4. PubMed ID: 7506824
[TBL] [Abstract][Full Text] [Related]
17. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors.
Tai KF; Chen PJ; Chen DS; Hwang LH
J Gene Med; 2003 May; 5(5):386-98. PubMed ID: 12731087
[TBL] [Abstract][Full Text] [Related]
18. [Spread of drug-resistant strains of mycobacterium tuberculosis among patients with isolated bacteria].
Zhukova MP
Probl Tuberk; 1998; (1):14-6. PubMed ID: 9553424
[TBL] [Abstract][Full Text] [Related]
19. Albumin fusion with granulocyte-macrophage colony-stimulating factor acts as an immunotherapy against chronic tuberculosis.
Chuang YM; He L; Pinn ML; Tsai YC; Cheng MA; Farmer E; Karakousis PC; Hung CF
Cell Mol Immunol; 2021 Oct; 18(10):2393-2401. PubMed ID: 32382128
[TBL] [Abstract][Full Text] [Related]
20. Orally administered Mycobacterium vaccae modulates expression of immunoregulatory molecules in BALB/c mice with pulmonary tuberculosis.
Hernández-Pando R; Aguilar D; Orozco H; Cortez Y; Brunet LR; Rook GA
Clin Vaccine Immunol; 2008 Nov; 15(11):1730-6. PubMed ID: 18827195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
